NCT03844191View on ClinicalTrials.gov

A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 18, 2019

Primary Completion Date

November 1, 2019

Study Completion Date

December 1, 2019

Conditions
Coronary Disease
Interventions
DRUG

RUC-4 Compound

single subcutaneous administration of RUC-4

Trial Locations (1)

45219

The Lindner Research Center, Cincinnati

Sponsors
All Listed Sponsors
collaborator

Precision For Medicine

INDUSTRY

collaborator

CirQuest Labs

UNKNOWN

collaborator

Syneos Health

OTHER

lead

CeleCor Therapeutics

INDUSTRY